This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Giannini, M. et al. Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups. Nat. Rev. Rheumatol. https://doi.org/10.1038/s41584-024-01105-9 (2024).
Khoo, T. et al. Epidemiology of the idiopathic inflammatory myopathies. Nat. Rev. Rheumatol. 19, 695–712 (2023).
Naveen, R., Rathore, U., Agarwal, V. & Gupta, L. Characteristics and outcomes of overlap myositis: a comparative multigroup cohort study in adults from the MyoCite cohort. Rheumatol. Int. 41, 551–563 (2021).
Dyball, S. et al. OP0013 Applying standard classificaton criteria excludes up to a half of all patients from connective tissue diseases (CTD) clinical trials. Ann. Rheum. Dis. 82, 9 (2023).
Lundberg, I. E. et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol. 69, 2271–2282 (2017).
Zanframundo, G. et al. Defining anti-synthetase syndrome: a systematic literature review. Clin. Exp. Rheumatol. 40, 309–319 (2022).
Saygin, D. et al. Current myositis clinical trials and tribulations. Ann. Rheum. Dis. https://doi.org/10.1136/ard-2023-224652 (2024).
Hum, R. M. et al. Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry. Rheumatology https://doi.org/10.1093/rheumatology/kead481 (2023).
Debrut, L. et al. Refining incidence and characteristics of inflammatory myopathies: a quadruple-source capture-recapture survey using the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria. Arthritis Rheumatol 75, 1850–1855 (2023).
Tilling, K. Capture-recapture methods—useful or misleading? Int. J. Epidemiol. 30, 12–14 (2001).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Khoo, T., Lilleker, J.B., Thong, B.YH. et al. Reply to: Current classification criteria underestimate the incidence of idiopathic inflammatory myopathies by ignoring subgroups. Nat Rev Rheumatol 20, 313–314 (2024). https://doi.org/10.1038/s41584-024-01106-8
Published:
Issue date:
DOI: https://doi.org/10.1038/s41584-024-01106-8